Compare

Pacific Biosciences of California, Inc. vs Quanterix Corp vs Harvard Bioscience Inc vs 908 Devices Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearPacific Biosciences of California, Inc.
PACB
Quanterix Corp
QTRX
Harvard Bioscience Inc
HBIO
908 Devices Inc.
MASS
Year ended2025-12-312025-12-312025-12-312025-12-31
Revenue$160.00M$138.90M$86.55M$56.20M
Revenue growth (YoY)+3.9%+1.1%-8.1%+17.7%
Gross margin28.6%46.8%57.7%50.6%
Operating margin-346.2%-90.4%-56.1%-70.1%
Net margin-341.5%-77.1%-65.5%34.7%
Net income-$546.38M-$107.15M-$56.70M$19.49M
EPS (Diluted)-$1.82-$2.51-$1.28$0.54
Operating cash flow-$111.21M-$77.24M$6.73M-$23.69M
Free cash flow-$113.92M-$79.85M$5.47M-$24.64M
Cash & equivalents$63.71M$29.84M$8.61M$70.52M
Total assets$784.08M$418.77M$80.07M$190.07M
Total liabilities$778.73M$123.04M$66.34M$46.37M
Shareholders' equity$5.35M$295.73M$13.73M$143.70M
Return on year-end equityn/m-36.2%-412.8%13.6%
Shares outstanding301.96M46.74M44.72M36.32M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearPacific Biosciences of California, Inc.Quanterix CorpHarvard Bioscience Inc908 Devices Inc.
Latest$160.00M
Ended 2025-12-31
$138.90M
Ended 2025-12-31
$86.55M
Ended 2025-12-31
$56.20M
Ended 2025-12-31
1 year earlier$154.01M
Ended 2024-12-31
$137.42M
Ended 2024-12-31
$94.14M
Ended 2024-12-31
$47.75M
Ended 2024-12-31
2 years earlier$200.52M
Ended 2023-12-31
$122.37M
Ended 2023-12-31
$112.25M
Ended 2023-12-31
$50.23M
Ended 2023-12-31
3 years earlier$128.30M
Ended 2022-12-31
$105.52M
Ended 2022-12-31
$113.33M
Ended 2022-12-31
$46.85M
Ended 2022-12-31
4 years earlier$130.51M
Ended 2021-12-31
$110.56M
Ended 2021-12-31
$118.90M
Ended 2021-12-31
$42.21M
Ended 2021-12-31